The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis

Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial

(2014) B. A. Steinberg et al.   EUROPEAN HEART JOURNAL

Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES

(2014) T. Vanassche et al.   EUROPEAN HEART JOURNAL

Clinical Outcomes of Persistent and Paroxysmal Atrial Fibrillation in Patients with Stroke

(2014) Ichiro Deguchi et al.   Journal of Stroke & Cerebrovascular Diseases

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2014) Craig T. January et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: Data from the GISSI-AF trial

(2013) Marcello Disertori et al.   BMC Cardiovascular Disorders

Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial

(2013) Sana M. Al-Khatib et al.   EUROPEAN HEART JOURNAL

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

A New Risk Scheme to Predict Ischemic Stroke and Other Thromboembolism in Atrial Fibrillation: The ATRIA Study Stroke Risk Score

(2013) Daniel E. Singer et al.   Journal of the American Heart Association

Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: Clinical correlates and the effect of rhythm-control therapy

(2012) Cees B. De Vos et al.   AMERICAN HEART JOURNAL

Stroke and Thromboembolism in Atrial Fibrillation

(2012) Ron Pisters et al.   CIRCULATION JOURNAL

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPEAN HEART JOURNAL

Efficacy and Safety of Dabigatran Compared to Warfarin in Patients With Paroxysmal, Persistent, and Permanent Atrial Fibrillation

(2012) Greg Flaker et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Real-Life Observations of Clinical Outcomes With Rhythm- and Rate-Control Therapies for Atrial Fibrillation

(2011) A. John Camm et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPACE

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?

(2008) R. Nieuwlaat et al.   EUROPEAN HEART JOURNAL

Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation

(2008) G. Y. H. Lip et al.   JOURNAL OF INTERNAL MEDICINE